Parties In OTC Cold Medicine Case Mull How FDA’s Statement Will Impact MDL
BROOKLYN, N.Y. — Parties in a multidistrict litigation stemming from allegations that over-the-counter cough and cold medications containing the active ingredient phenylephrine XE "phenylephrine" (PE) are ineffective at relieving nasal congestion...To view the full article, register now.
Already a subscriber? Click here to view full article